Skip to main content

Straumann agrees full takeover of Mininavident

| News

Straumann agrees full takeover of Mininavident

16.08.2024

The Basel-based dental provider Straumann has fully acquired Mininavident AG. The startup from Liestal has developed a guidance system for dental implantation procedures.

The navigation system for dental implants developed by Mininavident is now marketed under the name Straumann Falcon (image: Straumann)

The Straumann Group has fully acquired Mininavident AG from Liestal in the canton of Basel-Landschaft, as the company has now announced as part of its half-year reporting. Mininavident, which was founded in 2013 as a spin-off from the University of Basel and the University of Applied Sciences and Arts Northwestern Switzerland (FHNW), has developed a guidance system to support dentists in fitting implants. In this context, the workflow is digitized – starting with planning the position of the implant in 3D visualization all the way through to actually fitting the implant

Straumann had previously acquired a 39 percent stake in Mininavident back in October 2021, following which it played a part in the further development of the product alongside the startup. In July 2024, the dental services provider then acquired the remaining shares in Mininavident.

Straumann is perfect partner for Mininavident

“With Straumann, we have found the perfect partner to bring our system to world-wide application”, comments Michael Breitenstein, CEO of Mininavident AG, in a press release. “Straumann’s commitment to technology leadership fits very well with our DNA and we look forward to pursuing the market-oriented further development of our dynamic navigation for the benefit of surgeons and patients”, he adds.

Now that a full takeover has been concluded, the Mininavident guidance system is to be marketed and sold under the name Straumann Falcon.

You may also be interested in

Roche investing an additional 1.2 billion Swiss francs in Basel

Roche will be putting an additional 1.2 billion Swiss francs towards the renovation of its site in Basel. This investment...
Read More

Nouscom secures 67.5 million euros in financing

Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The Basel-based firm intends to use...
Read More

How open innovation in healthtech hubs is fueling the rise of digital healthcare

How the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of...
Read More

Paradigm shift in pain management

Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not...
Read More

Investors stump up 3.7 million Swiss francs in Onena Medicines

Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of the biotech startup incubator BaseLaunch...
Read More

Do you have a question? We'd like to hear from you.